4//SEC Filing
EVANS LAWRENCE R 4
Accession 0001927362-25-000017
CIK 0000277638other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 10:55 AM ET
Size
38.0 KB
Accession
0001927362-25-000017
Insider Transaction Report
Form 4
EVANS LAWRENCE R
EVP & GM, Surgery Company
Transactions
- Exercise/Conversion
Common Stock
2025-08-29$8.18/sh+4,000$32,720→ 214,599 total - Exercise/Conversion
Common Stock
2025-08-29$10.55/sh+3,630$38,297→ 224,629 total - Exercise/Conversion
Common Stock
2025-08-29$8.18/sh+8,400$68,712→ 237,029 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2025-08-29−4,000→ 0 totalExercise: $8.18From: 2017-06-28Exp: 2026-06-28→ Common Stock (4,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2025-08-29−3,630→ 0 totalExercise: $10.55From: 2020-06-12Exp: 2029-06-12→ Common Stock (3,630 underlying) - Exercise/Conversion
Common Stock
2025-08-29$8.80/sh+3,000$26,400→ 217,599 total - Exercise/Conversion
Common Stock
2025-08-29$12.10/sh+4,000$48,400→ 228,629 total - Sale
Common Stock
2025-08-29$25.50/sh−2,695$68,723→ 234,334 total - Exercise/Conversion
Common Stock
2025-08-29$8.80/sh+4,400$38,720→ 238,734 total - Exercise/Conversion
Common Stock
2025-08-29$9.55/sh+8,638$82,493→ 245,854 total - Sale
Common Stock
2025-08-29$25.50/sh−4,838$123,369→ 237,783 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2025-08-29−3,000→ 0 totalExercise: $8.80From: 2018-06-23Exp: 2027-06-23→ Common Stock (3,000 underlying) - Exercise/Conversion
Stock Appreciation Rights (2017)
2025-08-29−4,400→ 0 totalExercise: $8.80From: 2018-03-03Exp: 2027-03-03→ Common Stock (4,400 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2025-08-29−4,000→ 0 totalExercise: $12.10From: 2021-06-17Exp: 2030-06-17→ Common Stock (4,000 underlying) - Exercise/Conversion
Stock Appreciation Rights (2016)
2025-08-29−8,400→ 0 totalExercise: $8.18From: 2017-03-04Exp: 2026-03-04→ Common Stock (8,400 underlying) - Exercise/Conversion
Stock Appreciation Rights (2018)
2025-08-29−8,638→ 0 totalExercise: $9.55From: 2019-03-09Exp: 2028-03-09→ Common Stock (8,638 underlying) - Exercise/Conversion
Common Stock
2025-08-29$9.55/sh+3,400$32,470→ 220,999 total - Sale
Common Stock
2025-08-29$25.50/sh−1,518$38,709→ 237,216 total - Sale
Common Stock
2025-08-29$25.50/sh−3,233$82,442→ 242,621 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2025-08-29−3,400→ 0 totalExercise: $9.55From: 2019-06-28Exp: 2028-06-28→ Common Stock (3,400 underlying)
Holdings
- 37,536.272(indirect: By 401(k))
Common Stock
Footnotes (8)
- [F1]Exercise of SARs upon retirement.
- [F2]Payment of taxes in connection with SARs pay-out.
- [F3]This total reflects routine accumulation of 37,536.2717 common shares acquired through the Company's 401(K) benefit plan as of August 29, 2025, based on internal records.
- [F4]These options become exercisable in 20% installments on each anniversary of the grant date beginning June 28, 2017.
- [F5]These options become exercisable in 20% installments on each anniversary of the grant date beginning June 23, 2018.
- [F6]These options become exercisable in 20% installments on each anniversary of the grant date beginning June 28, 2019.
- [F7]These options become exercisable in 20% installments on each anniversary of the grant date beginning June 12, 2020.
- [F8]These options become exercisable in 20% installments on each anniversary of the grant date beginning June 17, 2021.
Documents
Issuer
DAVEY TREE EXPERT CO
CIK 0000277638
Entity typeother
Related Parties
1- filerCIK 0001927362
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 10:55 AM ET
- Size
- 38.0 KB